Agios Pharmaceuticals

About Agios Pharmaceuticals

Agios Pharmaceuticals is focused on discovering and developing novel drugs to treat cancer and inborn errors of metabolism, or IEMs, which are rare genetic metabolic diseases, through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutics areas, Agios has multiple first-in-class lead product candidates in cancer metabolism and IEMs in clinical and/or preclinical development. All Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism, biology and genomics.


DMPK Intern

June 2017 - August 2017 Cambridge, MA
“The work environment was great. They focused a lot on people working together, everyone had open offices and all of the employees were very friendly and welcoming.”
See All